[Whitepaper] Is Prior Authorization the Best Approach for Oncology?

The debate over prior authorization is particularly important in oncology, where rising drug costs and daily advances in research and emerging therapies make it difficult for health plans to ensure their members are getting the right treatment at the right time.

Is Prior Authorization the Best Approach for Oncology? explores the following: 

  • An overview of the challenges that are unique to oncology prior authorization, which impact health plans, providers and patients
  • Approaches to prior authorization that address the unique needs of all stakeholders and provide an opportunity to better manage costs, provider abrasion and patient outcomes


Sponsored by: